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Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-Specific Regulatory T 
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制する） 
Thesis Summary 
Langerhans cells (LCs) are antigen-presenting cells (APC) in the epidermis whose roles in 
antigen-specific immune regulation remain poorly understood. Desmoglein 3 (Dsg3) is a desmosomal 
glycoprotein expressed by keratinocytes and is the autoantigen targeted in pemphigus vulgaris. We 
hypothesized that LCs, given their proximity to keratinocyte-associated autoantigens, are the major APC 
to regulate torelogenic immune responses against Dsg3. 
To address our question, we first sought to determine via immunofluorescence microscopy 
whether LCs were capable of acquiring Dsg3 from surrounding keratinocytes. Detection of 
non-conformational epitopes of Dsg3 with LC cytoplasm suggested that LCs captured Dsg3 from 
surrounding keratinocytes. To confirm this, we generated mice that express a Dsg3-eGFP fusion protein 
driven by the keratin 5 promoter, which enabled us to detect Dgs3 by eGFP signals. Flow cytometry 
analysis of epidermal cells suspension revealed that up to 5% of LCs were eGFP+, indicating that a 
subset of LCs had taken up Dsg3 from surrounding keratinocytes.  
To determine the immunological consequence of Dsg3 uptake by LCs, we co-cultured LCs from 
unmanipulated WT (LCWT) mice as APC and Dsg3-reactive CD4+ T (H1rag) cells as responders. The 
responder cells underwent robust proliferation, which was completely blocked by antibodies against 
MHC class II (MHC II). Moreover, LCs from Dsg3-/- mice failed to activate H1rag cells, demonstrating that 
LCs acquire Dsg3 and present it in the context of MHC II in a Dsg3-specific manner. We hypothesized 
that the uptake of Dsg3, a highly glycosylated protein, is mediated by langerin. Langerin is a c-type lectin 
required for the formation of Birbeck granules and was demonstrated to be an endocytic receptor in 
vitro, but its roles in immune response remain unknown. When we co-stained langerin and Dsg3 in 
epidermal sheets prepared from WT mice, we observed co-localization of Dsg3 and langerin signals in 
LC cytoplasm. To explore the role of langerin in immune response, we utilized LCs from mice that lack 
functional langerin (LCDTR/DTR). LCDTR/DTR were impaired in their ability in vitro to activate H1rag cells, 
indicating that langerin mediated Dsg3 uptake prior to antigen presentation. Additional evaluation of 
phenotype of H1rag cells revealed that LC expanded both regulatory T (Treg) and effector T (Teff) cells. 
Because of LCWT expanded both Treg and Teff cells in vitro, we sought to confirm the role of LCs 
in Experimental Autoimmune Dermatitis (EAD) model, a CD4+ T cell-mediated autoimmune response 
against Dsg3. In this model, when H1 cells are adoptively transferred into Rag2-/- mice, they readily 
infiltrated the skin and elicit INF-γ-dependent response directed against keratinocytes, causing 
別表６ 
（３）                                    Keio University 
 
 
    Thesis Abstract                  No.      
apoptosis and obscuring the dermo-epidermal junction. Interestingly, EAD in mice that lack LCs 
exhibited an aggravated phenotype with significantly elevated clinical score and more prominent 
interface dermatitis. Moreover, re-stimulation of CD4+ T cells from lesional epidermis in vitro revealed an 
increase production of IL-17 as well as trend toward increased INF-γ. In addition, flow cytometry 
analysis of skin-draining lymph nodes revealed a decreased expansion of Treg cells in mice that lacked 
LCs. In aggregate, the results suggest that LCs suppress autoimmunity in vivo by expanding Treg cells. 
To explore the mechanism by which LCs expand Treg cells, we utilized WT CD4+ T cells as 
responder cells rather than H1rag cells because the activation of Teff and cytokines that they produce may 
have secondary effects on Treg cell expansion. Consistent with a previous report, LCs induced significant 
proliferation of Treg, but not Teff, demonstrating that LCs preferentially expanded Treg cells in the absence 
of autoimmune T cells. The Treg cells that proliferated may be specific for various epidermal self-antigens 
that were acquired by LCs. We added neutralizing antibodies against molecules that are involved in Treg 
cell induction and found that only anti-MHC II and anti-IL-2 antibodies had notable effects on Treg cell 
expansion. Blockage of IL-2 receptor α (CD25) had an effect similar to IL-2 neutralization. Furthermore, 
thymus derived Treg cell markers Helios and Neuropilin-1 were expressed by LC-expanded Treg cells. 
These data suggest that LCs mediate the expansion of naturally-occuring Treg cells, rather than induced 
Treg cells. 
The effect of IL-2 and CD25 blockage on Treg cells could be explained by direct effects on T 
cells. However, LCs highly upregulated CD25 upon emigration from epidermis, suggesting that IL-2 
might directly affect LCs. Indeed, signal transducer and activation of transcription 5 (STAT5) underwent 
phosphorylation (pSTAT5) in LC both the epidermis and lymph nodes of WT mice, indicating that IL-2 
signaling takes place in LCs. To further characterize the effect of IL-2 on LCs, LCs were exposed to rIL-2 
in vitro. Global transcripts analysis by Nanostring showed decreased expression of Citta, a regulator of 
MHC II, and increased tgfb1 and smad3, both of which are associated with TGF- β signaling and LC 
migration. To predict the biological significance of rIL-2-induced overall gene expression change in LCs, 
we performed Ingenuity Pathway Analysis and found that there were upregulation of pathways that were 
involved in cell motility and migration. Thus, IL-2 signaling in LC evokes a less activated but motile 
phenotype that may represent homeostatic migration of LCs that carry autoantigens. Finally, to 
determine the consequence of impaired IL-2 signaling in LCs during Treg cell proliferation, we utilized 
LCs from CD25-/- mice and found that CD25 on LCs was required for optimal Treg cell expansion and that 
the IL2-IL2 receptor axis in LCs conditioned them to expand Treg cells. 
In conclusion, these data establish that LCs take up Dsg3 via langerin and suppress 
autoimmunity by expanding regulatory T cells. In addition, IL-2 receptor signaling occurs in LCs 
conditioning them to mediate peripheral tolerance.  Exploring environmental cues that govern LCs’ 
immunological polarity should enable new strategies to control skin immunity and to achieve tolerogenic 
responses in autoimmune blistering diseases such as phemphigus. 
 
